Resting-state functional magnetic resonance imaging reveals functional connectivity alteration in the experimental

Pietro Bontempi1, Giusi Piccolantonio1, Alice Busato2,3

  • 1Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.

NMR in Biomedicine
|March 7, 2024
PubMed

Insights

Resting-state functional MRI (rsfMRI) shows altered brain connectivity in an animal model of multiple sclerosis (MS). rsfMRI may serve as a biomarker for MS progression and disability, aiding in therapy development.

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Multiple sclerosis (MS) is a central nervous system autoimmune disease.
  • Experimental autoimmune encephalomyelitis (EAE) is a key animal model for MS research.
  • Magnetic resonance imaging (MRI) and functional MRI (fMRI) are vital for studying MS and EAE.

Purpose of the Study:

  • To validate resting-state functional MRI (rsfMRI) as a biomarker for disease progression in the MOG35-55 induced EAE model of MS.
  • To investigate alterations in whole-brain functional connectivity (FC) during MS progression using rsfMRI.
  • To explore the relationship between FC changes, disease severity, and disability accumulation.

Main Methods:

  • Longitudinal MRI scans (rsfMRI) were acquired at 14, 25, and 50 days post-immunization in EAE and control groups.
  • Seed-based analysis was employed to assess whole-brain FC with specific regions (thalamus, cerebellum, cortex).
  • Disease progression was monitored using the cumulative disease index.

Main Results:

  • The EAE group showed altered FC and a decreasing trend in activated voxels compared to controls.
  • A significant shift in cerebellar FC was observed: hyperconnectivity early and reduced connectivity late in the disease.
  • A negative correlation was found between activated voxel count in the late phase and cumulative disease index.

Conclusions:

  • rsfMRI can serve as a biomarker for MS progression in the EAE model.
  • Cerebellar FC dynamics reflect disease stages, offering insights into disability.
  • The findings support rsfMRI as a tool for understanding MS pathophysiology and developing new therapies, potentially addressing the clinico-radiological paradox.